Co-Authors
This is a "connection" page, showing publications co-authored by Rebecca Kahn and Marc Lipsitch.
Connection Strength
4.511
-
Interpreting vaccine efficacy trial results for infection and transmission. Vaccine. 2021 07 05; 39(30):4082-4088.
Score: 0.950
-
Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies. Am J Epidemiol. 2021 02 01; 190(2):328-335.
Score: 0.927
-
Choices in vaccine trial design in epidemics of emerging infections. PLoS Med. 2018 08; 15(8):e1002632.
Score: 0.780
-
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials. Clin Trials. 2018 04; 15(2):207-211.
Score: 0.752
-
Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology. 2021 11 01; 32(6):820-828.
Score: 0.244
-
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. Eur J Epidemiol. 2021 Feb; 36(2):179-196.
Score: 0.233
-
Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic. JMIR Public Health Surveill. 2021 01 15; 7(1):e25538.
Score: 0.231
-
Antibody testing will enhance the power and accuracy of COVID-19-prevention trials. Nat Med. 2020 06; 26(6):818-819.
Score: 0.221
-
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug; 7:100150.
Score: 0.060
-
Practical considerations for measuring the effective reproductive number, Rt. PLoS Comput Biol. 2020 12; 16(12):e1008409.
Score: 0.057
-
Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study. Lancet Infect Dis. 2020 09; 20(9):1025-1033.
Score: 0.055